UnitedHealth Group (NYSE:UNH) Stock Price Up 4% Following Strong Earnings

UnitedHealth Group Incorporated (NYSE:UNH)’s stock price rose 4% on Wednesday following a stronger than expected earnings report. The company traded as high as $395.50 and last traded at $392.7760. Approximately 2,995,521 shares changed hands during mid-day trading, a decline of 59% from the average daily volume of 7,354,667 shares. The stock had previously closed at $377.76.

The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter in the prior year, the firm earned $2.59 EPS. UnitedHealth Group’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s payout ratio is currently 59.72%.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Third-quarter results exceeded expectations. Adjusted EPS was $4.69 versus the $4.14 consensus, while revenue of $112.7 billion topped estimates of $111.3 billion. Operating earnings increased 52% to $6.6 billion, helped by lower medical costs and improved execution. UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs
• Positive Sentiment: Management raised 2026 guidance. UnitedHealth now expects adjusted EPS of at least $20.50, above the roughly $19.86 analyst consensus, reinforcing confidence in recovering margins. UnitedHealth Group Reports Third Quarter 2026 Results
• Positive Sentiment: The 2027 outlook is improving. Executives highlighted a long-term earnings-growth target of 13% to 16%, potential margin recovery in Medicaid after 2026, and continued benefits from artificial intelligence. AI tools reportedly reduced clinical-review times by 33%, while the medical care ratio improved to 88.4%. UNH Q3 Earnings Call Highlights 2027 Growth and Margin Recovery
• Neutral Sentiment: Analyst opinion remains mixed. Mizuho maintained UnitedHealth as a top healthcare pick, while Barclays trimmed its target to $440 but kept an overweight rating. Baird cut its target to $427 and assigned a neutral rating. UnitedHealth Stock Forecast: TD Cowen Stays Cautious Even as Mizuho Names UNH a Top Pick
• Negative Sentiment: Risks remain around profitability. Commercial medical costs and Medicaid pressures continue to challenge margins, and some analysts lowered forecasts following the results. Revenue was essentially flat year over year, while the company’s Medicare business changes and membership reductions remain concerns for investors. UnitedHealth Analysts Slash Their Forecasts Following Q3 Results

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. Bank of America reissued a “buy” rating and set a $450.00 target price on shares of UnitedHealth Group in a research note on Monday, July 20th. TD Cowen dropped their price objective on UnitedHealth Group from $430.00 to $402.00 and set a “hold” rating on the stock in a report on Friday, October 9th. Wall Street Zen upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Erste Group Bank downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, August 27th. Finally, Mizuho boosted their target price on shares of UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a research report on Monday, July 20th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $461.66.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.19% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. raised its position in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after purchasing an additional 3,395,530 shares during the last quarter. State Street Corp grew its holdings in UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after buying an additional 301,081 shares during the last quarter. Bank of America Corp DE increased its position in UnitedHealth Group by 21.8% during the first quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock worth $3,169,606,000 after buying an additional 2,097,859 shares in the last quarter. Bank of New York Mellon Corp increased its position in UnitedHealth Group by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock worth $4,449,317,000 after buying an additional 616,723 shares in the last quarter. Finally, Wellington Management Group LLP raised its holdings in shares of UnitedHealth Group by 5.8% in the second quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock worth $4,436,923,000 after acquiring an additional 583,536 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The firm has a market capitalization of $352.55 billion, a PE ratio of 25.20, a P/E/G ratio of 1.42 and a beta of 0.60. The company has a 50-day moving average price of $387.44 and a 200-day moving average price of $382.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.